Yingying Ma

Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant

Cheng Zhang, Xiaoqi Wang, Rongli Zhang et al. · Leukemia · 2020 · 81 citations · Full text

Life Sciences, Hematology, Immunology +15

Preventive infusion of donor-derived CAR-T cells after haploidentical transplantation

Cheng Zhang, Yingying Ma, Jun Liu et al. · Medicine · 2019 · 17 citations · Full text

Life Sciences, Hematology, Immunology +15

AMD3100 and G-CSF disrupt the cross-talk between leukemia cells and the endosteal niche and enhance their sensitivity to chemotherapeutic drugs in biomimetic polystyrene scaffolds

Zhaohua Shen, Dongfeng Zeng, Peiyan Kong et al. · Blood Cells Molecules and Diseases · 2016 · 16 citations

Medicine, Oncology, Pharmacology +17

Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study

Yingying Ma, Zeliang Wei, Ya‐Jing Xu et al. · Cancer · 2023 · 16 citations · Full text

Medicine, Hematology, Oncology +17

Targeting of the leukemia microenvironment by c(RGDfV) overcomes the resistance to chemotherapy in acute myeloid leukemia in biomimetic polystyrene scaffolds

Zhaohua Shen, Dongfeng Zeng, Xiaoyan Wang et al. · Oncology Letters · 2016 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +17